Risk Assessment and Treat Compliance in Hypertension Education Trial

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's100 enrolled

Overview

The RATCHET study assesses if patient knowledge of estimated cardiovascular risk at current and recommended target blood pressure levels improves compliance in the management of hypertension.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

100

Conditions

Hypertension Dyslipidemia

Interventions

Knowledge of Cardiovascular Risk AssessmentBEHAVIORAL

Knowledge of Cardiovascular Risk Assessment and risk reduction at target BP, reviewed every 3-6 months.

Eligibility

Sex: ALLMin age: 30 YearsMax age: 84 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Essential hypertension (new diagnosis or established diagnosis) meeting criteria for pharmacologic therapy as defined by current guidelines Exclusion Criteria: * Lack of written informed consent * Previous myocardial infarction * Previous stroke * Congestive heart failure * Stage 3 or greater chronic kidney disease * Pregnancy * Usage of medication bubble/blister package

Locations (1)

University of Western Ontario

London, Ontario, Canada

Outcomes

Primary Outcomes

Medication Compliance

Time frame: 1 year

Secondary Outcomes

Patient perception of cardiovascular risk

Time frame: 1 year

Pilot Feasibility Study

Time frame: 1 year

Blood Pressure

Time frame: 1 year

Cholesterol Level

Time frame: 1 year

Framingham Risk Score (stroke and coronary artery disease)

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.